Search results
Is CVS Health Stock a Bargain Buy After Falling to Multi-Year Lows?
Motley Fool via Yahoo Finance· 1 day agoThe bigger problems were its rising expenses. Not only were insurance costs higher than expected,...
Medicare Advantage to be radically changed under new plan
Newsweek· 2 days agoMedicare Advantage plans could look dramatically different if a new law passes in the Senate. For...
Medicare Posts $12B Loss for 2023 | ThinkAdvisor
ThinkAdvisor· 6 days agoThe post-pandemic surge in health care use, the aging U.S. population and health care worker shortages hit Medicare hard in 2023. Payroll ...
Medicare, Social Security go-broke dates delayed in 'measure of good news' - Indianapolis Business...
Indianapolis Business Journal· 7 days agoMedicare’s go-broke date for its hospital insurance trust fund was delayed five years, to 2036, in...
Medicare, Social Security go-broke dates pushed back by strong economy
Federal Times· 6 days agoMedicare’s go-broke date for its hospital insurance trust fund was pushed back five years to 2036 in...
Social Security, Medicare go-broke dates pushed back; overfishing fears recede
The Post and Courier· 6 days agoMedicare’s go-broke date for its hospital insurance trust fund was pushed back five years to 2036 in...
Strong Labor Market Steadied Social Security and Medicare Funds
New York Times· 6 days agoThe financial health of Social Security and Medicare, two of the nation’s most crucial safety net...
AARP Medicare Advantage 2024 Review - NerdWallet
Nerdwallet· 2 days agoBacked by big hitter UnitedHealthcare, AARP Medicare Advantage plans have low-cost options and just-above-average star ratings.
Let’s integrate primary care and mental health care - The Boston Globe
The Boston Globe· 16 hours agoThe ability to find a behavioral health clinician — particularly one who can address a patient’s...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVS Health...
Morningstar· 10 hours agoNEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CVS Health Corporation (“CVS” or the “Company”) (NYSE: CVS). Such ...